Yanping Li
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer, Hypoxia, and Metabolism 9
- MicroRNA in disease regulation 4
- Breast Cancer Treatment Studies 3
-
- Metabolism, Diabetes, and Cancer 3
- Co-authors
- David Z. Qian (1 shared paper)Mu‐Shui Dai (1 shared paper)Hongjuan Cui (2 shared papers)Guanghui Zhang (2 shared papers)Rui Yang (2 shared papers)Xiu‐Lan Sun (1 shared paper)Lihu Zhang (1 shared paper)Meng Li (1 shared paper)
- Journals
- Medicine (2 papers)Biochemical Pharmacology (2 papers)Breast Cancer Targets and Therapy (1 paper)Frontiers in Cell and Developmental Biology (1 paper)Clinical Breast Cancer (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Yanping Li
32 papers receiving 480 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 218
- Oncology 110
- Molecular Biology 254
- Immunology 59
- Genetics 28
Countries citing papers authored by Yanping Li
This map shows the geographic impact of Yanping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanping Li more than expected).
Fields of papers citing papers by Yanping Li
This network shows the impact of papers produced by Yanping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanping Li. The network helps show where Yanping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 91 | |
| 2 | 2020 | 69 | |
| 3 | 2020 | 66 | |
| 4 | 2021 | 45 | |
| 5 | 2021 | 30 | |
| 6 | 2022 | 27 | |
| 7 | 2021 | 22 | |
| 8 | 2023 | 17 | |
| 9 | 2018 | 15 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 11 | |
| 12 | 2019 | 9 | |
| 13 | 2022 | 8 | |
| 14 | 2019 | 8 | |
| 15 | 2022 | 6 | |
| 16 | 2022 | 5 | |
| 17 | 2024 | 5 | |
| 18 | 2015 | 5 | |
| 19 | 2021 | 5 | |
| 20 | 2022 | 5 |
About Yanping Li
Yanping Li is a scholar working on Cancer Research, Molecular Biology, Oncology, Immunology and Pathology and Forensic Medicine, having authored 34 papers that have together received 483 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (9 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer Cells and Metastasis (5 papers), MicroRNA in disease regulation (4 papers), Immunotherapy and Immune Responses (4 papers), Immune cells in cancer (4 papers), Metabolism, Diabetes, and Cancer (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Cancer Research (218 citations), Oncology (110 citations), Molecular Biology (254 citations), Immunology (59 citations) and Genetics (28 citations). Yanping Li has collaborated with scholars based in China, United States and France. Frequent co-authors include David Z. Qian, Mu‐Shui Dai, Hongjuan Cui, Guanghui Zhang, Rui Yang, Xiu‐Lan Sun, Lihu Zhang, Meng Li, Hongtao Xu and Hongyan Wu. Their work appears in journals such as Medicine, Biochemical Pharmacology, Breast Cancer Targets and Therapy, Frontiers in Cell and Developmental Biology and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.